Info

Clinical trials for leukaemia in Romania

Which trials are taking patients now, in which cities, and what to ask your doctor. The official record stays with the national agency.

← All cancer types

How to read this list

Each row is an authorised trial looking for participants. The plain-language title is written by our editorial team, and underneath it you can see the original registry title — so you can check for yourself that we did not change the meaning. We cannot tell you whether you are eligible, and we do not publish the hospital name: the international registry does not carry it, and a wrong name would send you to a room where nobody expects you. For the centre and the team's contact details, open the official record.

Trials recruiting now

0 of 18 titles have been rewritten in plain language by our editorial team. The rest still show the registry's protocol wording.

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

A treatment is being testedPhase 3

Running in: GC2202 Study Site 503, Brașov · GC2202 Study Site 511, București · GC2202 Study Site 506, Cluj-Napoca · GC2202 Study Site 507, Constanța · GC2202 Study Site 510, Iași · GC2202 Study Site 502, Timișoara

See the official record ↗ NCT05645107

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

A treatment is being testedPhase 2

Running in: Fundeni Clinical Institute, București · Institutul Oncologic Cluj, Cluj-Napoca · Spitalul Clinic Municipal Filantropia Craiova, Craiova · Institutul Regional de Oncologie, Iași · Ovidius Clinical Hospital OCH, Ovidiu

See the official record ↗ NCT06588478

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

A treatment is being testedPhase 2

Running in: Centrul de Diagnostic si Tratament Oncologic Brasov ( Site 1802), Brașov · Spitalul Clinic Colțea ( Site 1805), București · Institutul Regional de Oncologie Iasi ( Site 1801), Iași · Ovidius Clinical Hospital ( Site 1804), Ovidiu

See the official record ↗ NCT04728893

A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)

A treatment is being testedPhase 3

Running in: Ascentage Investigative Site #6503, București · Ascentage Investigative Site #6502, Cluj-Napoca · Ascentage Investigative Site #6507, Craiova · Ascentage Investigative Site #6504, Iași

See the official record ↗ NCT06051409

Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

A treatment is being testedPhase 3

Running in: Clinical Trial Site, București · Clinical Trial Site, Cluj-Napoca · Clinical Trial Site, Iași · Clinical Trial Site, Târgu Mureș

See the official record ↗ NCT07211958

Global Trial in APG2575 for Patients With CLL/SLL

A treatment is being testedPhase 3

Running in: Ascentage Investigative Site, București · Ascentage Investigative Site, Cluj-Napoca · Ascentage Investigative Site, Timișoara

See the official record ↗ NCT06104566

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A treatment is being testedPhase 3

Running in: Coltea Clinical Hospital, București · Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca · Institutul Regional de Oncologie Iasi, Iași

See the official record ↗ NCT06973187

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

A treatment is being testedPhase 3

Running in: Coltea Clinical Hospital, București · Institutul Clinic Fundeni, Bucureti · Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca, ClujNapoca

See the official record ↗ NCT07277231

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

A treatment is being testedPhase 2

Running in: IInsitutul Clinic Fundeni, Sectia de Transplant Medular, București · University of Medicine and Pharmacy V. BABES, Emergency Children's Hospital LOUIS TURCANU, III. Clinic of Pediatrics , Department of Onco-hematology and Bone Marrow Transplantation, Timișoara

See the official record ↗ NCT01949129

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Renal Impairment

A treatment is being testedPhase 1

Running in: Institutul Oncologic Bucuresti - Prof. Dr. Alexandru Trestioreanu, București · Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca

See the official record ↗ NCT04953897

Study to Evaluate the Pharmacokinetics and Safety of Oral Decitabine and Cedazuridine in Cancer Patients With Hepatic Impairment

A treatment is being testedPhase 1

Running in: Institutul Oncologic Bucuresti - Prof. Dr. Alexandru Trestioreanu, București · Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca

See the official record ↗ NCT04953910

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

A treatment is being testedPhase 3

Running in: Institutul Clinic Fundeni, București · Institutul Regional de Oncologie Iasi, - Haematology Department, Iași

See the official record ↗ NCT05429632

Asciminib Roll-over Study

A treatment is being testedPhase 4

Running in: Novartis Investigative Site, Timișoara

See the official record ↗ NCT04877522

Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)

A treatment is being testedPhase 2

Running in: Fundeni Clinical Institute /ID# 241614, București

See the official record ↗ NCT04895436

IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

A treatment is being testedPhase 3

Running in: Fundeni Clinical Institute, București

See the official record ↗ NCT06713837

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

A treatment is being testedPhase 2

Running in: ARENSIA research clinic at the Oncology Institute "Prof. Dr. Ion Chiricuţă", Cluj-Napoca

See the official record ↗ NCT06788756

Master Framework For Relapse or Refractory Acute Myeloid Leukemia

Observational study — you do not receive a new treatment

Running in: Fundeni Clinical Institute, București

See the official record ↗ NCT06459024

A Real-world Study of Ibrutinib and Venetoclax (I+V) First-Line Treatment Given for Fixed-duration of Time in Participants With Chronic Lymphocytic Leukemia

Observational study — you do not receive a new treatment

Running in: Spitalul Universitar de Urgenta Bucuresti, București

See the official record ↗ NCT07602088

Source: ClinicalTrials.gov, the public registry of the US National Library of Medicine. Read automatically, last on 31 Jul 2026.

Worth reading before you talk to your doctor

Material from our library to help you prepare your questions.

Where the official information lives

The road ends at the registry, not with us. That is where each trial's full record is — including the things we do not publish.

Studii Clinice România (ANMDMR) ↗ClinicalTrials.gov ↗

Where the data on this page comes from

The counts are read automatically from ClinicalTrials.gov and show trials marked there as recruiting, with at least one site in Romania. We do not verify each one by hand, and we cannot guarantee that a trial marked “recruiting” is still taking patients today — the registry lags behind what happens in the hospital. For any decision, the official record and your doctor have the final word.